Table of Contents Author Guidelines Submit a Manuscript
Infectious Diseases in Obstetrics and Gynecology
Volume 2012, Article ID 137192, 4 pages
http://dx.doi.org/10.1155/2012/137192
Clinical Study

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz

1Division of Infectious Diseases, University of Colorado Denver, 1635 Aurora Court, Mail Stop B-163, Aurora, CO, USA
2Warren Alpert Medical School, Brown University, Providence, RI 02906, USA

Received 14 October 2011; Accepted 19 December 2011

Academic Editor: Jean R. Anderson

Copyright © 2012 Monica L. Carten et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. HIV/AIDS Surveillance Report, Cases of HIV and AIDS in the United States and Dependent Areas, 2007.
  2. UNAIDS, AIDS Epidemic Update: December 2005.
  3. Sustiva (Efavirenz) Capsule and Tablets.US Prescribing Information, Bristol-Myers-Squibb, Princeton, NJ, USA, 2010.
  4. A. Saitoh, A. D. Hull, P. Franklin, and S. A. Spector, “Myelomeningocele in an infant with intrauterine exposure to efavirenz,” Journal of Perinatology, vol. 25, no. 8, pp. 555–556, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Fundarò, O. Genovese, C. Rendeli, E. Tamburrini, and E. Salvaggio, “Myelomeningocele in a child with intrauterine exposure to efavirenz,” AIDS, vol. 16, no. 2, pp. 299–300, 2002. View at Google Scholar · View at Scopus
  6. M. De Santis, B. Carducci, L. De Santis, A. F. Cavaliere, and G. Straface, “Periconceptional exposure to efavirenz and neural tube defects,” Archives of Internal Medicine, vol. 162, no. 3, p. 355, 2002. View at Google Scholar · View at Scopus
  7. L. S. Massad, G. Springer, L. Jacobson et al., “Pregnancy rates and predictors of conception, miscarriage and abortion in US women with HIV,” AIDS, vol. 18, no. 2, pp. 281–286, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. H. Van Benthem, I. De Vincenzi, M. C. Delmas et al., “Pregnancy bfore and after HIV diagnosis in a European cohort of HIV-infected women. European study on the natural history of HIV infection in women,” AIDS, vol. 14, no. 14, pp. 2171–2178, 2000. View at Google Scholar
  9. L. B. Finner and S. K. Henshw, “Disparities in rates of unintended pregnancy in the United States, 1994–2001,” Perspect Sex Reprod Health, vol. 38, no. 2, pp. 9–96, 2006. View at Google Scholar
  10. Plan B (LNG0.75) Tablets, US Prescribing Information, Barr Pharmaceuticals Inc., Pomona, NY, US, 2006.
  11. Task Force on Postovulatory Methods of Fertility Regulation, “Randomized controlled trial of levonorgestrel versus the yuzpe regimen of combined oral contraceptives for emergency contraception,” The Lancet, vol. 352, no. 9126, pp. 428–433, 1998. View at Google Scholar
  12. S. E. Cohn, J. G. Park, D. H. Watts et al., “Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions,” Clinical Pharmacology and Therapeutics, vol. 81, no. 2, pp. 222–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Sevinsky, T. Eley, A. He, D. Persson et al., “Effect of efavirenz on the pharmacokinetics of ethinyl estradiol and norgestimate in healthy female subjects,” in Proceedings of the 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC, USA, October 2008.
  14. A. Matiluko, L. Soundararjan, P. Hodston et al., “Early contraceptive failure of implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovudine, lamivudine and efavirenz,” Journal of Family Planning and Reproductive Health Care, vol. 33, no. 4, pp. 277–278, 2007. View at Google Scholar
  15. K. Kook, H. Gabelnick, and G. Duncan, “Pharmacokinetics of levonorgestrel 0.75 mg tablets,” Contraception, vol. 66, no. 1, pp. 73–76, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Gandhi, L. Benet, P. Bacchetti et al., “Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women,” Journal of Acquired Immune Deficiency Syndromes, vol. 50, no. 5, pp. 482–491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. El-Ibiary and J. Cocohoba, “Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives,” European Journal of Contraception and Reproductive Health Care, vol. 13, no. 2, pp. 123–132, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Vogler, K. Patterson, L. Kamemoto et al., “Contraceptive efficacy of oral and transdermal hormones when co-administered with protease inhibitors in HIV-1-infected women: pharmacokinetic results of ACTG trial A5188,” Journal of Acquired Immune Deficiency Syndromes, vol. 55, no. 4, pp. 473–482, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents, “US Department of Health and Human Services,” 2010, http://www.aidsinfo.nih.gov/guidelines/adult/AA 100606.pdf.
  20. P. Crawford, D. J. Chadwick, C. Martin, J. Tjia, D. J. Back, and M. Orme, “The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids,” British Journal of Clinical Pharmacology, vol. 30, no. 6, pp. 892–896, 1990. View at Google Scholar · View at Scopus
  21. J. Sidhu, S. Job, S. Singh, and R. Philipson, “The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects,” British Journal of Clinical Pharmacology, vol. 61, no. 2, pp. 191–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Barditch-Crovo, C. B. Trapnell, E. Ette et al., “The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive,” Clinical Pharmacology and Therapeutics, vol. 65, no. 4, pp. 428–438, 1999. View at Google Scholar · View at Scopus